Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, +17

The Lancet Oncology

Zoledronic AcidBreast OncologyOncologyEndocrine-related CancerEndocrine Oncology +8

Inferring expressed genes by whole-genome sequencing of plasma DNA

Peter Ulz, Gerhard Thallinger, Martina Auer, +9

Nature Genetics

Dna SequencingPlasma DnaFunctional GenomicsSequencingNext-generation Sequencing +5

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection

Peter Ulz, Samantha Perakis, Qing Zhou, +18

Nature Communications

Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer

Ellen Heitzer, Martina Auer, Eva Maria Hoffmann, +19

International Journal of Cancer

Cancer PathologyPathologyTumor BiologyPlasma DnaOncology +14

The dynamic range of circulating tumor DNA in metastatic breast cancer

Maryam Heidary, Martina Auer, Peter Ulz, +11

Breast Cancer Research

Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy

Arnim Bader, Dietmar Schlembach, Karl Tamussino, +2

The Lancet Oncology

Metastatic Breast CancerOncologyBreast OncologyMedicineGynecology +3

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson, +249

The Lancet Oncology

Breast OncologyMedicineCancer ManagementGynecologyBreast Cancer +5

Neonatal outcome and two‐year follow‐up after expectant management of second trimester rupture of membranes

Gunda Pristauz, Margit Bauer, U. Maurer-Fellbaum, +4

International Journal of Gynecology & Obstetrics

Androgen receptor expression in breast cancer patients tested for <i>BRCA1</i> and <i>BRCA2</i> mutations

Gunda Pristauz, Edgar Petru, Elvira Stacher, +5

Histopathology

Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families

Christian F. Singer, M. Tea, Gunda Pristauz, +4

Wiener klinische Wochenschrift

Breast OncologyCancer DetectionCancer ScreeningHereditary BreastMedicine +10